TABLE 4.
EARLY | ||||||||
---|---|---|---|---|---|---|---|---|
GD12.5 | GD13.5 | GD14.5 | GD15.5 | |||||
+/+ | −/− | +/+ | −/− | +/+ | −/− | +/+ | −/− | |
Col1a1 | 2.2±0.1 | 3.5±0.3 | 8.7±0.2 | 12.0±0.5 | 9.3±0.1 | 8.6±0.4 | 10.6±0.2 | 17.4±0.6 |
Col2a1 | 1.3±0.1 | 1.5±0.9 | 3.2±0.2 | 5.0±0.1 | 2.6±0.2 | 1.3±1.0 | 2.3±1.3 | 4.3±0.1 |
Sox9 | 1.5±0.3 | 1.1±1.1 | 1.5±0.4 | 1.1±1.1 | 1.1±0.3 | 1.1±1.1 | 1.2±0.8 | 1.3±0.8 |
MID | ||||||||
Runx2 | 1.2±0 | 1.6±0.5 | 1.6±0.2 | 3.7±0.1 | 1.1±0.6 | 1.9±0.4 | 1.2±1.4 | 3.0±0.4 |
Acan | 5.1±1.7 | 5.6±1.0 | 4.8±1.6 | 16.3±1.8 | 8.7±2.1 | 14.6±1.7 | 19.3±3.4 | 30.3±2.8 |
LP-1 | 2.9±0.1 | 3.1±0.3 | 1.4±0.4 | 1.5±0.5 | 2.80±.3 | 6.2±0.4 | 4.0±0.2 | 9.8±0.5 |
Has-2 | 2.8±0.7 | 1.6±0.4 | 1.8±0.3 | 1.1±1.1 | 2.70±.2 | 1.6±0.4 | 1.8±0.3 | 1.4±0.4 |
1404 | 6.4±0.1 | 2.7±0.2 | 2.2±0.2 | 1.1±1.1 | 3.0±0.2 | 1.6±0.6 | 3.3±0.2 | 1.4±0.7 |
LATE | ||||||||
Osx/Sp7 | 5.2±0.1 | 4.2±0 | 7.6±0.3 | 8.1±0 | 8.6±0.4 | 8.4±0 | 13.5±0.2 | 8.9±0.2 |
Satb2 | 1.7±0.2 | 1.2±0.7 | 1.0±1.0 | 1.4±0.5 | 1.5±0.3 | 1.0±0 | 1.8±0.4 | 1.1±1.1 |
Opn | 4.1±1.4 | 1.5±0.5 | 3.5±0.8 | 1.3±1.1 | 37.3±2.6 | 29.4±1.1 | 92.4±5.7 | 49.9±1.6 |
Akp | 4.9±1.4 | 7.7±0.2 | 10.2±0.4 | 1.5±0.3 | 10.8±0.5 | 12.0±0.3 | 17.9±0.6 | 10.3±0.4 |
MUSCLE-SPECIFIC | ||||||||
Myogenin | 4.3±0.3 | 2.3±0.5 | 3.2±0.2 | 1.1±1.1 | 5.9±0.3 | 4.0±0.6 | 1.6±0.7 | 4.8±0.6 |
Mandibles were dissected on GD11.5-GD15.5 from wild-type and Prdm16−/− embryos/fetuses, RNA prepared and cDNAs synthesized and analyzed by real-time PCR for the expression of early (proliferation/condensation), mid (differentiation), and late (ossification) processes of chondro/osteogenesis. The data are expressed as the relative level (mean ± S.D.) on days 12.5–15.5 of gestation compared to the level on day 11.5.
P < 0.01, one-way ANOVA. The data are representative of 2 independent sets of samples assayed in triplicate.